Beta Secretase Inhibition as a means to treat Alzheimer’s Disease

Inventor

Prof Ralph Martins, Centre of Excellence for Alzheimer’s Disease Research and Care.

Applications

Pharmaceutical Industry.

IP status

No patent has been filed.

Current status

Addressing the underlying cause of Alzheimer’s disease by developing agents to attenuate the enzyme responsible for beta amyloid production.